Skip to Main Content

Author Details

Jorge Nieva
Norris Comprehensive Cancer Center, University of Southern California
1995
88
33
PMIDPaper TitleJournal TitlePublished Year
36598811Advancing Digital Health Innovation in Oncology: Priorities for High-Value Digital Transformation in Cancer Care.J Med Internet Res2023
37853341Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing.BMC Cancer2023
37703814Florida-California Cancer Research, Education and Engagement (CaRE<sup>2</sup>) Health Equity Center: Structure, Innovations, and Initial Outcomes.Cancer Control2023
37700839Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer.Front Oncol2023
37547097Response to Letter to the Editor Titled "Seize the Opportunity With Small Tissue Samples: The Tailor Teaches!"JTO Clin Res Rep2023
37611343Real world prognostic utility of platelet lymphocyte ratio and nutritional status in first-line immunotherapy response in stage IV non-small cell lung cancer.Cancer Treat Res Commun2023
37090100Biopsy Method and Needle Size on Success of Next-Generation Sequencing in NSCLC: A Brief Report.JTO Clin Res Rep2023
37451930Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked.Clin Lung Cancer2023
36841727A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non-Small Cell Lung Cancer.Clin Lung Cancer2023
36743179Characterization of mortality and high-risk characteristics of thyroid cancer in Filipinos using the California Cancer Registry.Front Public Health2023
36895917Understanding KRAS for better targeting.Transl Lung Cancer Res2023
34480094NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types.Br J Cancer2022
35605888Effect of sponsor on enrollment criteria in non-small cell lung cancer clinical trials.J Cancer Policy2022
35902325Evaluating Real World Mutational Differences Between Hispanics and Asians in NSCLC at a Large Academic Institution in Los Angeles.Clin Lung Cancer2022
36167819Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer.NPJ Breast Cancer2022
35159025Characterization of Cellular and Acellular Analytes from Pre-Cystectomy Liquid Biopsies in Patients Newly Diagnosed with Primary Bladder Cancer.Cancers (Basel)2022
34127515Clinical management of immune-related adverse events following immunotherapy treatment in patients with non-small cell lung cancer.J Investig Med2021
34917263Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas.Oncotarget2021
35261474COVID-19 and the acceleration toward remote cancer care.Proc (Bayl Univ Med Cent)2021
34439258Blood-Based Multi-Cancer Detection Using a Novel Variant Calling Assay (DEEPGEN<sup>TM</sup>): Early Clinical Results.Cancers (Basel)2021
34518295Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer.Mol Cancer Ther2021
34482103Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC).Lung Cancer2021
31605793A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study.J Thorac Oncol2020
31838007Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.Lancet Oncol2020
31978562Preanalytical Variables for the Genomic Assessment of the Cellular and Acellular Fractions of the Liquid Biopsy in a Cohort of Breast Cancer Patients.J Mol Diagn2020
33203646Treatment response and tumor evolution: lessons from an extended series of multianalyte liquid biopsies in a metastatic breast cancer patient.Cold Spring Harb Mol Case Stud2020
32970482Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters.JCO Clin Cancer Inform2020
32598179Quantified Kinematics to Evaluate Patient Chemotherapy Risks in Clinic.JCO Clin Cancer Inform2020
32391273A Systematic Review of the Efficacy of Preclinical Models of Lung Cancer Drugs.Front Oncol2020
32314030Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors.Cancer Chemother Pharmacol2020
30467768A new anion exchange purification method for Cu stable isotopes in blood samples.Anal Bioanal Chem2019
31903162Single cell correlation analysis of liquid and solid biopsies in metastatic colorectal cancer.Oncotarget2019
31681560Mandatory Research Biopsy Requirements Delay Initiation of Clinical Trials.Front Oncol2019
31462312Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer.J Transl Med2019
31313047Patient reported outcomes can improve performance status assessment: a pilot study.J Patient Rep Outcomes2019
31446141Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer.J Thorac Oncol2019
30988082Detection of NRG1 Gene Fusions in Solid Tumors.Clin Cancer Res2019
30651320Tuberculosis following PD-1 blockade for cancer immunotherapy.Sci Transl Med2019
30620678Radiomics in Pulmonary Lesion Imaging.AJR Am J Roentgenol2019
29144792Effect of Blood Collection Tube Type and Time to Processing on the Enumeration and High-Content Characterization of Circulating Tumor Cells Using the High-Definition Single-Cell Assay.Arch Pathol Lab Med2018
29803824Low-dimensional dynamical characterization of human performance of cancer patients using motion data.Clin Biomech (Bristol, Avon)2018
29743553When it comes to genomic analysis of tumours, don't buy in bulk.Br J Cancer2018
28904890Biophysical technologies for understanding circulating tumor cell biology and metastasis.Transl Lung Cancer Res2017
30283700Development of metastatic brain disease involves progression through lung metastases in <i>EGFR</i> mutated non-small cell lung cancer.Converg Sci Phys Oncol2017
28446544Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival.Cancer Epidemiol Biomarkers Prev2017
27694157A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer.Oncologist2016
25593015A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma.Oral Oncol2015
28721371Spatiotemporal progression of metastatic breast cancer: a Markov chain model highlighting the role of early metastatic sites.NPJ Breast Cancer2015
25989094Oncolytic viruses: perspectives on clinical development.Curr Opin Virol2015
24736064Adrenal metastases in lung cancer: clinical implications of a mathematical model.J Thorac Oncol2014
  • 1 - 50 of 88

Recommended Authors

Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 0
Stephanie S Yee
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 0
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
Chad V Pecot
University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 2
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 1
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 0
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 4
Minya Pu
University of California
Career Start Year 2003
Number of shared co-authors 0
Keyue Ding
Queen's University
Career Start Year 2002
Number of shared co-authors 0
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 1
Joshua M Lang
19University of Wisconsin Carbone Cancer Center.
Career Start Year 2000
Number of shared co-authors 4
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 1
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 3
Thomas J George
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 1
David Elashoff
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 0
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 0
Nam Bui
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Katherine S Panageas
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 1
Paul Mitchell
Olivia Newton-John Cancer Research Institute
Career Start Year 1993
Number of shared co-authors 1
Craig Gedye
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 2
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Career Start Year 1992
Number of shared co-authors 4
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 0
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 6
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Career Start Year 1989
Number of shared co-authors 0
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 1
Mark Lawler
Queens University Belfast Belfast
Career Start Year 1988
Number of shared co-authors 0
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 3
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 1

Collaborators

Peter Kuhn
University of Tubingen
Co-authored papers 29
Kelly Bethel
Scripps Clinic Medical Group
Co-authored papers 21
Anand Kolatkar
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 16
Paul K Newton
University of Southern California
Co-authored papers 9
James Hicks
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 7
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Co-authored papers 4
Jerry S H Lee
University of Southern California
Co-authored papers 4
Joanne Xiu
Co-authored papers 4
Luciano Nocera
University of Southern California
Co-authored papers 4
Bing Xia
Xijing Hospital, The Fourth Military Medical University
Co-authored papers 4
Sriram Yennu
University of Texas MD Anderson Cancer Center
Co-authored papers 4
Cyrus Shahabi
University of Southern California.
Co-authored papers 4
Zaki Hasnain
University of Southern California
Co-authored papers 3
Sean E Hanlon
Drew University, National Institutes of Health, Rutgers University New Brunswick, University of North Carolina at Chapel Hill
Co-authored papers 3
Larry Norton
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Alexander Drilon
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Marcella May
Dornsife Center for Self-Report Science, University of Southern California
Co-authored papers 2
David I Quinn
USC Norris Comprehensive Cancer Center
Co-authored papers 2
Tanachat Nilanon
University of Southern California
Co-authored papers 2
Joan E Broderick
Dornsife Center for Self-Report Science, University of Southern California
Co-authored papers 2
Douglas M Fowler
University of Washington, USA Brotman Baty Institute for Precision Medicine
Co-authored papers 1
Ming Li
Keck School of Medicine, University of Southern California
Co-authored papers 1
Helen J Ross
Mayo Clinic
Co-authored papers 1
David Spetzler
Co-authored papers 1
Julie E Bauman
George Washington University
Co-authored papers 1
John D Carpten
Co-authored papers 1
James C Barton
University of Alabama at Birmingham
Co-authored papers 1
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Co-authored papers 1
Ryan Dittamore
Decipher Biosciences Inc.
Co-authored papers 1
Wendy Cozen
Co-authored papers 1
Release 1.2